Cold EMR for large proximal colonic adenomas: a single center preliminary results
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S463
DOI: 10.1055/s-0044-1783870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von A. Repici und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Conventional endoscopic mucosal resection (C-EMR) is the standard of care for the treatment of large colorectal adenomas without submucosal invasive carcinoma (SMIC). However, the use of electrocautery during EMR poses inherent risks, including potentially perforation and bleeding, both intraprocedurally and delayed. In contrast, cold snare EMR (CS-EMR), avoiding the use of current, is currently the new trend in treating large colorectal serrated lesions as well as large sporadic non ampullary duodenal adenomas. This study aims to assess the feasibility, safety and efficacy of CS-EMR of proximal large (>20 mm) colorectal adenomas.
Methods
We prospectively enrolled all cases of CS-EMR for large (>20 mm) proximal adenomas with low SMIC risk between July 2022 and September 2023. Technical success, defined as the ability complete the procedure, was primary evaluated. Safety was explored by the mean of bleeding and perforation (intraprocedurally and delayed). Efficacy was defined as the absence of residual or recurrent adenomatous tissue during the first surveillance colonoscopy -6 months after index procedure- (SC1) and second surveillance colonoscopy – 12 months after index procedure-(SC2).
Results
A total of 56 lesions in 52 patients were included in the study. Technical success was achieved in all procedures (100%) with no adverse events (0%). A recurrence rate of 5.2% (2 patients) was observed at SC1 (38/56 patients with available followup); all recurrences were successfully re-treated with cold snare (CSP) or cold forceps (CFP) polypectomy in the same procedure. No recurrences were detected during at SC2 (12/52 patients with available follow-up).
Conclusions
In this initial study CS-EMR demonstrated both excellent technical feasibility and safety profile in treating proximal, large colorectal adenomas. Regarding efficacy, we demonstrated a very high performance, with a 94.8% recurrence- free patients at 6 months and few recurrences endoscopically treated in the same session. Longer follow-up, as well as large-volume, prospective trials are needed to validate its efficacy. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Repici, A., Maselli, R., Capogreco, A., Massimi, D., Fiacca, M., Mastrorocco, E., Sire, R. D., Alfarone, L., Galtieri, A., Facciorusso, A., & Hassan, C. (2024). Cold EMR for large proximal colonic adenomas: a single center preliminary results. Endoscopy, 56(S 02 S 02), S463. https://doi.org/10.1055/s-0044-1783870
Vancouver
Repici A, Maselli R, Capogreco A, Massimi D, Fiacca M, Mastrorocco E, et al. Cold EMR for large proximal colonic adenomas: a single center preliminary results. Endoscopy. 2024;56(S 02 S 02):S463. doi:10.1055/s-0044-1783870
BibTeX
@article{Repici2024,
author = {Repici, A. and Maselli, R. and Capogreco, A. and Massimi, D. and Fiacca, M. and Mastrorocco, E. and Sire, R. de and Alfarone, L. and Galtieri, A. and Facciorusso, A. and Hassan, C.},
title = {Cold EMR for large proximal colonic adenomas: a single center preliminary results},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S463},
doi = {10.1055/s-0044-1783870}
}
EUVIMED